Feedback / Questions
IMG-007 - Inmagene
https://www.globenewswire.com/news-release/2025/04/24/3067491/0/en/Inmagene-Reports-Topline-Results-from-Phase-2a-Study-of-IMG-007-a-Nondepleting-Anti-OX40-Monoclonal-Antibody-with-an-Extended-Half-life-in-Patients-with-Alopecia-Areata.html
Apr 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next